Cabot Undervalued Stocks Advisor Special Bulletin
Two stocks have rating changes today.
Read More
Two stocks have rating changes today.
Read More
The market has generally taken a bit of a breather, with the major indexes relatively flat for the week as of this morning.
Read More
Small caps continue to move higher so keep leaning bullish, but be mindful that we’re near a resistance area and that it’s equally likely we will see some softness as it is that we will see more strength.
Read More
The market remains in good shape, though near-term, pullbacks and potholes are possible given the big run and the fact that we’re finally seeing a few leaders hit resistance. Long story short, we think the market will go higher over time, though we’re through...
Read More
Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More
Trends remain good for investors in the marijuana industry.
Read More
One of our portfolio stocks reported Q4 2018 results the other night that were better than expected.
Read More
These growth investing rules have been carefully selected as the most important guidelines a growth investor can use in a successful investment program.
Read More
One stock reports strong fourth quarter and moves from Strong Buy to Hold; a second falls on temporary problems.
Read More
From Cabot Growth Investor
The market remains in good shape, though near-term, pullbacks and potholes are possible given the big run and the fact that we’re finally seeing a few leaders hit resistance. But the intermediate-term trend is up, the longer-term trend is on the of...
Read More
This digital entertainment and e-commerce company is expected to grow at double-digit rates this quarter, boosting its shares’ momentum.
Read More
MedTech Stocks: Stable, Yet Defensive Growth
Medical technology, or MedTech, stocks, have long been a favorite for growth investors due to the attractive qualities of gradual, long-term growth in a relatively defensive industry. Throw in M&A potential and it’s not hard to see why group...
Read More
Don’t ever forget about the dividends. A couple months ago we were spiraling into a recession and bear market. Now, things look good. There’s a reason that dividends have accounted for 44% of market returns over the last hundred years.
Read More
I have always admired large blue chip stocks. They are tremendous organizations, full of executive talent and with tentacles spread out all over the world. Doors open for their CEOs wherever they go, from the corridors of power in New York or Washington overseas...
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses a bit of rotation he’s seeing out there—over time, it’s a good thing, though near-term he’s starting to see some leaders (not all) take a rest. Still, the good news is two...
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses a bit of rotation he’s seeing out there—over time, it’s a good thing, though near-term he’s starting to see some leaders (not all) take a rest. Still, the good news is two...
Read More
U.S. stocks continue to defy gravity, with their audacious 2019 year-to-date gains mirroring their equally extreme fourth quarter 2018 descent.
Read More
The worst monthly retail report in nine years did nothing to slow the momentum in retail stocks. But what does it mean for the sector going forward?
Read More
Marijuana stocks have been red-hot of late, for four key reasons. And subscribers to my Cabot Marijuana Investor advisory have reaped the benefits.
Read More